Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02429336
Other study ID # 11-01368-XP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2012
Est. completion date June 30, 2020

Study information

Verified date November 2020
Source University of Tennessee
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to collect data that will be generated during an office visit. The data will be gathered and analyzed in research studies that will help with the investigators understanding of various medical conditions. About 200 subjects will be participating in this study. Participation in this study will not require a patient's time or presence. The medical information contained in a patient's chart from the office visit, including the results of any tests that were ordered at that time, will be transferred to an anonymous database and analyzed together with data from other patients who have similar condition/s. No follow-up information will be collected. The following information will be collected from a patient's medical record: the medical history and a list of the current medications.


Description:

Purpose: To collect the characteristics of patients presenting to the reproductive endocrinology clinic. Rationale: Patients' characteristics will be analyzed as part of clinical research studies and may help in understanding the causes of their condition.


Recruitment information / eligibility

Status Completed
Enrollment 194
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender Female
Age group 8 Years and older
Eligibility Inclusion Criteria: - females of childbearing potential experiencing reproductive endocrinology related problems Exclusion Criteria: - male or female not of childbearing potential

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Regional One Health Ob-Gyn Clinic Memphis Tennessee

Sponsors (1)

Lead Sponsor Collaborator
University of Tennessee

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Data collection from patients' charts. Data collection from patients' charts. up to 1 year from the time of signing the informed consent for data collection
See also
  Status Clinical Trial Phase
Completed NCT02429349 - Preservation of Ovarian Tissue and Chemo-Radiotherapy N/A
Completed NCT02431884 - Tissue Samples and Bodily Fluid Specimens Banking